Table 10.
Summary results for the four autism assessment tools, for the Arizona and National groups combined.
| Placebo-Pre | Placebo-Post | Difference | Supplement- Pre |
Supplement Post |
Difference | P-Value | |
|---|---|---|---|---|---|---|---|
| PGI-R (Average Change) |
+0.34 +/- 0.54 |
+0.67 +/- 0.65 |
0.008 | ||||
| ATEC (Total) | 59 +/- 28 |
50 +/- 27 |
-9.6 | 63 +/- 22 |
51 +/- 20 |
-11.9 | n.s. |
| SAS | 5.2 +/- 2.6 |
5.2 +/- 2.6 |
0.0 | 5.4 +/- 2.0 |
5.1 +/- 2.2 |
-0.3 | n.s. |
| PDD-BI (Autism Composite) |
-66 +/- 64 |
-79 +/- 68 |
-13.4 | -62 +/- 51 |
-78 +/- 52 |
-16.4 | n.s. |
Note that the ATEC, SAS and PDD-BI are assessed at the beginning and end of the study, whereas the PGI-R is only assessed at the end, as it only evaluates the changes observed. Only the PGI-R found a significant difference between the supplement and placebo groups, so it is highlighted in a bolder font.